Urinalysis market to reach USD 6.98B by 2030

The report delves into a comprehensive analysis of the urinalysis market, highlighting its current size and projected growth trajectory. With a valuation of USD 4.06 billion in 2022, Global Urinalysis Market is poised to reach USD 6.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7% during the forecast period spanning from 2023 to 2030. This growth can be attributed to various factors, including the increasing prevalence of urinary tract infections, kidney diseases, and diabetes, which drive the demand for urinalysis testing. Moreover, advancements in urinalysis technologies and the introduction of automated systems enhance the accuracy and efficiency of diagnostic procedures, further propelling market growth. Additionally, the rising adoption of point-of-care urinalysis devices in decentralized healthcare settings contributes to market expansion. The report also analyzes emerging trends such as the integration of artificial intelligence and machine learning algorithms in urinalysis devices for improved diagnostics and personalized treatment approaches. Furthermore, it examines regional market dynamics, regulatory landscapes, and competitive strategies adopted by key market players to provide stakeholders with actionable insights and facilitate informed decision-making.

Urinalysis plays a crucial role in the diagnosis, monitoring, and management of various medical conditions affecting the urinary system, including UTIs, kidney diseases, diabetes, liver disorders, and metabolic abnormalities. Urinalysis tests assess the physical, chemical, and microscopic properties of urine samples to detect abnormalities, infections, and diseases, enabling healthcare providers to make informed clinical decisions and initiate appropriate treatment interventions.

Urinalysis market growth drivers
The growth of the urinalysis market is being primarily driven by an increasing prevalence of urinary tract infections, kidney diseases, and diabetes worldwide. Additionally, the rising geriatric population, who are at a higher risk of developing these conditions, is also contributing to the market’s expansion. Technological advancements in urinalysis devices and the shift towards automated systems for faster and more accurate results are further boosting market growth. Moreover, the growing awareness about preventive healthcare measures and regular screening programs among individuals is driving demand for urinalysis tests. The availability of convenient point-of-care testing options and the integration of artificial intelligence in urine analysis systems are expected to fuel market growth even further in the coming years. Overall, these factors combined are driving significant growth in the urinalysis market as professionals seek reliable tools to enhance their diagnostic capabilities and improve patient outcomes.

Key regional development
The market was dominated by North America, with a revenue share of 38.3% in 2022. Strategic initiatives taken by the major players, for example licensing agreements, to expand their business footprint can be attributed to this dominant position. According to a study by the National Center for Biotechnology Information (NCBI) in November 2021, it is estimated that approximately 40% of women in the U.S. are likely to develop a UTI during their lifetime due to high prevalence of uncomplicated urinary tract infections.

The Asia Pacific region is projected to grow at a compound annual growth rate of 5.7% during the forecast period. SNS Insider